UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FITB
301
Fifth Third Bancorp
FITB
$51.3B
| $61.8M | 0.07% |
2,938,380
-37,052
| -1% | -$726K |
|
302
Ross Stores
ROST
$81B
| $61.4M | 0.07% |
1,639,228
+54,724
| +3% | +$2.06M |
|
303
Agilent Technologies
A
$39.2B
| $61.3M | 0.07% |
1,499,246
-113,611
| -7% | -$4.32M |
|
304
Public Service Enterprise Group
PEG
$38.6B
| $61.1M | 0.07% |
1,908,242
-174,991
| -8% | -$5.79M |
|
305
Zimmer Biomet
ZBH
$18.4B
| $60.9M | 0.07% |
672,753
-74,189
| -10% | -$6.42M |
|
|
WFM
306
DELISTED
Whole Foods Market Inc
WFM
| $60.7M | 0.07% |
1,050,449
+33,002
| +3% | +$1.96M |
|
307
Dover
DOV
$27.5B
| $60.7M | 0.07% |
937,787
+67,347
| +8% | +$4.12M |
|
308
Teradata
TDC
$2.88B
| $60.4M | 0.07% |
1,328,053
-2,792,286
| -68% | -$127M |
|
309
Bread Financial
BFH
$4.47B
| $60.2M | 0.07% |
286,763
+8,860
| +3% | +$1.69M |
|
310
Mattel
MAT
$4.42B
| $59.8M | 0.07% |
1,256,882
+245,862
| +24% | +$11M |
|
311
Hershey
HSY
$35.9B
| $59.7M | 0.07% |
613,895
+22,200
| +4% | +$2.13M |
|
312
Humana
HUM
$44B
| $59.6M | 0.07% |
577,483
+10,727
| +2% | +$1.05M |
|
|
BBBY
313
DELISTED
Bed Bath & Beyond Inc
BBBY
| $59.2M | 0.07% |
737,505
+30,977
| +4% | +$2.4M |
|
314
Parker-Hannifin
PH
$121B
| $59.2M | 0.07% |
459,969
-754,375
| -62% | -$87.7M |
|
315
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
| – | – |
0
| – | – |
|
316
BioMarin Pharmaceuticals
BMRN
$11.7B
| $59.1M | 0.07% |
841,428
-67,517
| -7% | -$4.59M |
|
317
Weyerhaeuser
WY
$16.9B
| $58.8M | 0.07% |
1,861,836
+147,854
| +9% | +$4.42M |
|
318
Netflix
NFLX
$305B
| $58.7M | 0.07% |
11,165,070
+847,980
| +8% | +$4.16M |
|
319
Teck Resources
TECK
$30.7B
| $58.5M | 0.07% |
2,247,837
+17,609
| +0.8% | +$455K |
|
320
O'Reilly Automotive
ORLY
$71.3B
| $57.9M | 0.07% |
6,748,590
+146,925
| +2% | +$1.24M |
|
|
TYC
321
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $57.5M | 0.07% |
1,339,070
+54,047
| +4% | +$2.1M |
|
|
IPXL
322
DELISTED
Impax Laboratories, Inc.
IPXL
| $57.5M | 0.07% |
2,287,838
+180,514
| +9% | +$4.03M |
|
|
FISV
323
Fiserv Inc
FISV
$28.8B
| $57.5M | 0.07% |
1,946,736
-89,916
| -4% | -$2.43M |
|
324
Edison International
EIX
$30.3B
| $57.4M | 0.07% |
1,238,807
-712,944
| -37% | -$33.7M |
|
325
Trip.com Group
TCOM
$29.3B
| $57.3M | 0.07% |
+2,309,000
| New | +$60.2M |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.